TCS Wins Five Eventex Awards for Innovative Marketing Campaigns
Tata Consultancy Services , a leading
global IT services, consulting and business solutions organization, has won three gold Eventex Awards for its
ThisRun campaign and the Virgin Money London Marathon Event App, as well as two bronze awards for
excellence across marketing and customer engagement.
ThisRun received the gold award in both the People’s Choice Marketing Campaign and Technology
Marketing Campaign categories as well as a Bronze in the Grand Prix marketing campaign category.
ThisRun
is part of TCS’ drive to deliver innovative solutions that promote better health and inclusion. Launched in
2020, it is a worldwide campaign that brings runners together for better health and empowers them with
technology innovation. Through inspirational stories, tools and tips, #ThisRun imaginatively captures the
power of sport to unite people, help them grow and push boundaries in order to challenge the status quo.
TCS developed the Virgin Money London Marathon Event App to allow participants and spectators to get the fullest London Marathon experience. In 2020, TCS updated the app to support participants in the first virtual London Marathon during the pandemic, which included a digital certificate and medal, and the chance for runners to share an official finish line selfie. This year’s hybrid London Marathon event in October will see TCS further enhance and personalize the app experience. Over the last year, new technology innovations introduced by TCS have helped to reimagine many of the world’s top marathons as virtual events, and enabled runners across the world to participate
“During a year that saw physical marathons cancelled, all activities under ThisRun and our support of virtual marathons across the globe have contributed to the health and wellbeing of the community,” said Sapthagiri Chapalapalli, Head, TCS Europe. “We are delighted to win these awards that recognize TCS’ endeavor to develop digital solutions that motivate, unite and connect runners.”
TCS was also recognized for its excellence across customer engagement with a bronze in the Customer Engagement Event category for its flagship customer event TCS Summit Europe 2019. Over the years the TCS Summit has transformed itself into the premier event for senior leaders in Europe. In 2019, it celebrated 14 years of enabling debate of the issues of highest concern to European businesses and political circles. Over 100 of the region’s foremost business, sports, community and political leaders have addressed its previous editions, including eight heads of government from across the region.
“Huge congratulations to TCS! Every accolade is based entirely on merit and acknowledges the company’s fantastic creativity, flexibility, and drive for innovation,” said Ovanes Ovanessian, Co-founder, Eventex Awards.
The Eventex Awards 2021 received a record-breaking 561 entries from 37 countries. Founded in 2009 to celebrate creativity, innovation and effectiveness in the industry, today Eventex Awards is one of the most esteemed accolades in the world of events and experiential marketing. Every year the competition highlights the best agencies, events, and technology from the world of events.
Glenmark Pharmaceuticals receives ANDA approval for
Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials
Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials, the generic version of BROVANA®1 Inhalation Solution, 15 mcg/2 mL, of Sunovion Pharmaceuticals Inc. Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials will be manufactured in the company’s North American manufacturing facility based in Monroe, North Carolina, and marks the company’s first nebulizer approval.
According to IQVIATM sales data for the 12 month period ending April 2021, the BROVANA® Inhalation Solution, 15 mcg/2 mL market2 achieved annual sales of approximately $437.9 million*.
Commenting on the launch, Sanjeev Krishan, President, Glenmark North America said, “We are very excited to be one of the first generic companies to receive approval for such an important product for our customers. This also marks our third approval from our state-of-the art manufacturing facility in Monroe in 2021, demonstrating our capability to offer high quality medicines with affordable access across multiple dosage platforms.”
Glenmark’s current portfolio consists of 172 products authorized for distribution in the U.S. marketplace and 44 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
Dabur Breaks Ground for new Factory in Madhya Pradesh To invest Rs 550 Crore in setting up most modern, environment-friendly unit
Responding to the Government's Make in India policy push and Honourable Prime Minister Mr. Narendra Modi's clarion call for the building an Atmanirbhar Bharat, India’sleading Ayurvedic Healthcare company Dabur India Ltd today commenced construction of its largest, mostmodern and environment-friendly manufacturing facility in Madhya Pradesh. Being set up with a phased investment of around Rs 550 Crore, this new unit would manufacture a range of Dabur's Food Products, Ayurvedic Medicines and Health Supplements.
A ground-breaking ceremony was organised at the site today, which was attended by Dabur India Ltd. Executive Director-Operations Mr. Shahrukh A Khan and senior officials from the state government. The ground-breaking ceremony was limited to a small group to respect social distancing norms and COVID standard operating procedures.
The first phase of construction of this new facility – which has been planned under the Mega Projects Scheme of the Madhya Pradesh Government as well as the Central Government's Production-Linked Incentive (PLI) scheme – is scheduled for completion by the end of 2021-22 financial year. Located in the SMART Industrial Park near Indore, this unit would provide direct cum indirect employment to around 1,250 people initially and over 3,000 people at the end of the final phase.
"This project is the largest single investment by Dabur in the state of Madhya Pradesh, and is a clear commitment on our part towards promoting the traditional science of Ayurveda. We have a clear growth strategy in mind and in order to achieve our ambitious goals, we need modern, state-of-theart, high-performance plants. This new facility will provide us the space needed to rapidly expand our production capacity to not only satisfy the growing demand for Ayurvedic products and medicines but also develop and launch innovative Food Products for the future. The new factory is a step forward towards strengthening our position as the world's largest Ayurvedic products and medicines manufacturer and a market leader in Indian Foods and Beverages category" Dabur India Limited Chief Executive Officer Mr. Mohit Malhotra said.
Since the COVID outbreak, demand for Ayurvedic products has seen a rapid growth. Building on its 137-year-long heritage, Dabur has been developing products based on Ayurveda to support the consumers' growing need for holistic health and well-being. "This significant investment reflects Dabur's confidence in the future of Ayurveda and our strong commitment to Madhya Pradesh as a strategic manufacturing hub," Dabur India Ltd Executive Director-Operations Mr. Shahrukh A Khan said.
Spread over 51 acres of land, this new plant will become one of the largest manufacturing facilities for Dabur worldwide and possess cutting edge technology to make world class products. “The plant would feature fully automated processing and packing lines as well as state-of-the-art warehousing infrastructure to optimize supply chain and quality management. With its stringent quality control mechanism and highly hygienic production environment in place, consumers can be sure that products coming out of this factory will offer best-in-class quality while adhering to world-class Good Manufacturing Practice (GMP) standards,” Mr. Khan added.
As part of Dabur's strong commitment to "Green Company" principles, the new facility will incorporate energy conservation in its design and operation. Special focus is also being given to the Environment with the company planning to construct an energy efficient building besides deploying state-of-theart technology for effluent treatment. Dabur will also extend its Corporate Social Responsibility (CSR) programmes to the local community as part of its commitment to community development in areas where it operates.
Cyient Celebrates First Anniversary of IC Design and Development Center in Duisburg, Germany
- Investment aims to broaden expertise and service offerings of custom turnkey ASICs
and semiconductors for customers worldwide
- Increase presence in industrial, automotive, medtech markets across Central Europe
AnSem, a Cyient company, announced the first anniversary of the acquisition of an integrated circuit (IC) design center in Duisburg, Germany. By delivering innovation on chip, AnSem has always supported its global customers across industrial, automotive, medical, and semiconductor industries by revolutionizing their respective markets. The addition of another facility further strengthens AnSem’s capability in the digital design flow for large System on Chip (SoCs) and production test development.
These acquisitions are a reflection of Cyient’s ambition to grow exponentially in the Semiconductor industry. Cyient’s design and delivery centers are recruiting in the US, Germany, Belgium, and India to strengthen their teamsin order to meet the needs of their customers.
At present, the Duisburg centerhas over 25 highly skilled ASIC and semiconductor design engineers, with an average experience of 20 years. Further, it houses all disciplines to execute standalone ASIC projects successfully, remain a trusted turnkey design and development partner for its customers, and provide semiconductor design services, including physical design custom layout, test, and verification and validation through proven in-house capabilities as well as robust ecosystem partnerships.
Commenting on the occasion, Andrew Smith, Head of the Semiconductor Business, Cyient, and General Manager of Ansem, said, “Our best guarantee for excellence in customer service, project execution, and a faster time-to-market is by being closer to our customers. This design center with highly experienced design engineers is embedded within the network of Cyient semiconductor design centers and perfectly located to serve key customers in the region.”
With three different locations in Europe—Leuven (Belgium), Enschede (The Netherlands), and Duisburg (Germany)—and three locations in India (Hyderabad, Pune, and Bangalore), Cyient can now seamlessly deliver turnkey ASIC solutions, digital verification, and back - end/custom analog services worldwide.
“We are pleased to expand our footprint in Duisburg. This additional design center reaffirms Cyient’s ambition to remain the leading custom turnkey ASIC supplier. With our strong momentum and growth, including in our semiconductor business, we look forward to cyient.com 2 leveraging our presence in Germany to support customers globally,” said Karthik Natarajan, Executive Director and Chief Operating Officer at Cyient.
Germany is the heart of R&D and manufacturing for global industrial and automotive
markets. Duisburg’sstrategically located design center brings AnSem even closer to industry
leaders in these segments and strongly underlines Cyient’s commitment to serving these
markets with custom turnkey mixed-signal ASIC solutions.
Cipla receives final approval for generic version of Sunovion Pharmaceuticals, Inc.’s Brovana® (Arformoterol Tartrate Inhalation Solution 15 mcg/ 2mL)
Cipla and hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL from the United States Food and Drug Administration (US FDA).
Cipla’s Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana®
Brovana® is a long-acting beta-2 adrenergic agonist (beta-2 agonist) indicated for:
• Long-term, twice daily (morning and evening) administration in the
maintenance treatment of bronchoconstriction in patients with chronic
obstructive pulmonary disease (COPD), including chronic bronchitis and
emphysema.
According to IQVIA (IMS Health), Brovana® had US sales of approximately
$438M for the 12-month period ending April 2021.
The product is available for shipping immediately.
ABB completes melt shop digitalization project with India’s leading steel
company, boosting productivity and
profitability
Digital solution connects steel melt shop operations with ladle and crane tracking and thermal loss prediction for higher casting speeds and additional output of 24,000 tonnes per annum
ABB has built on a long-term relationship with JSW Steel Ltd, India’s leading steel company, by integrating its digital solution ABB Ability™ Smart Melt Shop into a wider expansion at Dolvi Works plant in Maharashtra state.
With the project, completed on schedule in March 2021, ABB has improved productivity and energy efficiency for the steel melt shop by developing an operations optimization solution, including ladle and crane tracking system, crane scheduling system and thermal loss models, to predict target temperature for ladle furnaces and ensure the correct superheat at the caster. This is expected to increase the company’s EBITDA profit by around USD two million per annum through four percent higher casting speeds, time savings of one working day per month and additional output equating to 24,000 tonnes a year.
The plant now has real time tracking of steel ladles for process synchronization and better maintenance planning. In wider benefits, the lower energy consumption means fewer consumables used per batch and therefore a lower carbon footprint with less CO₂ per tonne of steel produced. Automatic tracking and scheduling increases personnel safety as they are removed from the production area during crane and ladle movements. The scheduling solution also results in reducing tapping delays by ensuring these movements are synchronized with process requirements.
It is an example of overcoming one of the major challenges facing steelmakers today, which is to maintain the optimal temperatures required to make molten steel while balancing high electrical energy costs. Ensuring the right temperature at the right time, together with other parameters in the molten steel, directly determines steel quality and productivity. ABB’s Industry 4.0 led solution minimizes temperature superheat deviation and thermal losses resulting in higher caster speeds by around four percent, improved productivity, energy efficiency and steel quality.
“We relied on the metallurgical expertise of ABB’s Metals team as they proved to us that this digital solution could be integrated into our complex plant with its diversified operational procedures,” said Gajraj Singh Rathore, President, JSW Steel Ltd. “The figures and the results from testing stacked up and we could see the capacity to enhance productivity, improve energy efficiency and generate a relativity quick return on investment too.”
“Based on advanced digital algorithms and mathematical modeling, ABB Ability™ Smart Melt Shop is a true example of technology convergence as it utilizes cameras and image-processing, weighing systems, radar, laser and wireless-based technologies to ensure steel melt shops operate at optimum levels where crane and ladle tracking and their availability are critical to the entire steelmaking process.” said Tarun Mathur, Global Product Manager and Digital Lead for Metals, ABB.
“Our data from performance testing has shown significant increase in superheat compliance, returning time savings equating to more than nine hours per month and nearly 2,000 additional tonnes produced per month,” said Amit Kumar Chakraborty, Project Manager for Metals, ABB.
Additional benefits of the ladle tracking system include reduction in tapping delays in the electric arc furnace, reduction of electrode and power consumption at the ladle furnace and reduction in silicon deviation in hot rolled coils produced from slabs from the continuous caster.
A complete range of products, services and end-to-end solutions that improve productivity, quality, safety and cost-efficiency in iron, steel, aluminium and other metals production processes are available through ABB. Across the whole metals value chain, ABB demonstrates a commitment to optimize operations with high performance products and digital solutions.
Data collected from public sources